Super Bowl LIV is here. Time for some blow-out beer commercials, occasionally interrupted by the 49ers and Chiefs.
But who needs a Super Bowl-party when you can tackle this month’s selection of notable news stories, intercepted for you from the Drug Channels gridiron:
- Fumble: Express Scripts will stop buying generic drugs with Walgreens
- Trick play: Amazon signals global pharmacy ambitions
- Pass interference: The gross-to-net bubble for Humira
- Touchdown! ABC’s CEO pens a good letter to the editor
- Defensive line: Competition still lowers prices, say the FDA
Plus, the new Miss America is … a PharmD student?
P.S. Join the nearly 8,800 followers of my daily musings and links to neat stuff at @DrugChannels on Twitter. My recent tweets have highlighted best practices for biosimilar adoption, white bagging, hospital profits, 340B program oversight, insulin economics, the innovation ecosystem, California’s bonkers idea for generic drugs, Baby Yoda, and much more.
Read more »
Source: Post feed
